13F HOLDINGS REPORT
Catalys Pacific, LLC
Quarter ended Q2 2024 · Filed August 13, 2024 · Accession 0001104659-24-088833
Total Value
$132.5M
Positions
3
Other Managers
0
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Mineralys Therapeutics, Inc. | MLYS | 9,194,579 | $107.6M | 81.19% |
| 2 | HilleVax, Inc. | 43157M102 | 1,208,974 | $17.5M | 13.19% |
| 3 | Phathom Pharmaceuticals, Inc. | PHAT | 721,962 | $7.4M | 5.61% |